Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Ds Healthcare Cmn (DSKX) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 19,090
  • Shares Outstanding, K 20,250
  • Annual Sales, $ 11,780 K
  • Annual Income, $ -10,740 K
  • 36-Month Beta 0.50
  • Price/Sales 2.60
  • Price/Book 2.09
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.55 +21.82%
on 04/04/16
1.63 -58.90%
on 03/07/16
-0.89 (-57.05%)
since 03/04/16
3-Month
0.55 +21.82%
on 04/04/16
2.65 -74.72%
on 01/06/16
-1.89 (-73.83%)
since 01/04/16
52-Week
0.55 +21.82%
on 04/04/16
4.96 -86.49%
on 06/19/15
-0.17 (-20.24%)
since 04/02/15

Most Recent Stories

More News
DS Receives Staff Determination Letter From NASDAQ

Company Will Appeal Denial of 180 Day Extension Period

DS Healthcare Receives Third Notice of Failure to Satisfy Continued Listing Rule

POMPANO BEACH, FL / ACCESSWIRE / August 22, 2016 / DS Healthcare Group, Inc. (NASDAQ: DSKX) (the "Company") received a letter from Nasdaq dated August 19th, 2016 indicating that Nasdaq had not received...

DS Healthcare Increases Distribution to Grow Global Brand Awareness

DS Laboratories is pleased to announce new distribution at leading online retailers in both China and the US. These are two focus markets for DS Healthcare in 2016 and will enable a whole new group of...

DS Healthcare Group names Mark Brockelman to executive team

Biotechnology company DS Healthcare Group reported on Wednesday that it has appointed Mark Brockelman to help scale a market-leading health and wellness powerhouse that is focused on technologically advanced,...

Miami Dolphins CFO Joins DS Healthcare

Mark Brockelman has joined DS Healthcare Group to help scale its innovative organization into a market-leading health and wellness powerhouse focused on technologically advanced, consumer-driven personal...

DS Healthcare Announces $5 Million Registered Direct Offering to Finalize Senior Debt Requirements

DS Healthcare Group, Inc. (Nasdaq: DSKX) (the "Company" or "DSKX") announced that it entered into a definitive securities purchase agreement with certain institutional investors for the issuance of 2,000,000...

Rapid Expansion in Nutricosmetic Products Market Fuels Increased Sales Opportunities & High Margin Growth Potential Led by New Product Launches & Large Retail Store Distribution Partnerships

The U.S. & global growing population of the individuals within the age group of 40-60 years is driving the market for nutricosmetic, anti-aging products and other skin-care/treatment products indicating...

DS Healthcare Launches in Walmart Brazil

DS Healthcare Group's flagship products are now selling in Walmart, one of Brazil's largest retailers. With this addition, DS Laboratories further expands its global retail footprint as part of the company's...

Letter to Shareholders from DS Healthcare's New CEO

DS Healthcare today announced it has posted a letter to its shareholders. The letter can found by clicking here.

Dr. Antonella Tosti, MD joins DS Healthcare team

DS Healthcare Group today announced that world-renowned Physician, Dermatologist, and Scientist Dr. Antonella Tosti has joined the DS Laboratories team as esteemed Medical Advisor. Dr. Tosti is an Italian...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

DS Healthcare Group, Inc. is engaged in developing products for skin care, personal care, and hair care. It markets its products through a network of specialty retailers, spas, salons, and other distributors primarily in North America, Europe, Asia, and South America. DS Healthcare Group, Inc., formerly...

See More

Support & Resistance

2nd Resistance Point 0.92
1st Resistance Point 0.80
Last Price 0.67
1st Support Level 0.55
2nd Support Level 0.42

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.